QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stegink, L. D. Articles by Mcdonnell, J. E. Search for Related Content PubMed PubMed Citation Articles by Stegink, L. D. Articles by Mcdonnell, J. E.

Effect of an Abuse Dose of Aspartame upon Plasma and Erythrocyte Levels of Amino Acids in Phenylketonuric Heterozygous and Normal Adults^1,2,

Departments of Pediatrics, Biochemistry and the Child Development Clinic, The University of Iowa College of Medicine, Iowa City, IA 52242

Plasma and erythrocyte levels of free amino acids were measured in five female subjects known to be heterozygous for phenylketonuria and six subjects assumed to be normal (three male, three female) who were administered an abuse dose of aspartame (100 mg/kg) in orange juice. Small increases in plasma aspartate levels were noted 30 minutes after aspartame loading in both groups, with mean (±SD) levels increasing from 0.15 ± 0.05 µmoles/100 ml to 0.43 ± 0.23 µmoles/100 ml in normal subjects (P = 0.02), and from 0.49 ± 0.23 µmoles/100 ml to 0.80 ± 0.56 µmoles/100 ml in heterozygous subjects (P > 0.05). However, plasma aspartate levels remained within normal post-prandial levels in each case. Erythrocyte aspartate levels were unchanged in both groups. In normal subjects, plasma phenylalanine levels (mean ± SD) increased from fasting levels (5.40 ± 1.05 µmoles/100 ml) to mean peak values of 20.2 ± 6.77 µmoles/100 ml. In heterozygous subjects, mean peak plasma phenylalanine levels were approximately twice as high (41.7 ± 2.33 µmoles/100 ml), and the area under the plasma concentration-time curve twice as large. Peak plasma phenylalanine levels, however, were below those associated with toxic effects. The data indicate slower, but adequate metabolism and clearance of an abuse dose of aspartame by the phenylketonuric heterozygote.

KEY WORDS: • aspartame • phenylalanine • phenylketonuria

¹ Supported in part by a grant-in-aid from G. D. Searle, Skokie, IL.

² These data were presented in preliminary form at the 1979 meeting of the American Institute of Nutrition, Fed. Proc. 38, 708.

Manuscript received 31 March 1980.

This article has been cited by other articles:

				S. A. Mackey and C. M. Berlin JR Effect of Dietary Aspartame on Plasma Concentrations of Phenylalanine and Tyrosine in Normal and Homozygous Phenylketonuric Patients Clinical Pediatrics, July 1, 1992; 31(7): 394 - 399. [Abstract] [PDF]

				Council on Scientific Affairs Aspartame: Review of Safety Issues JAMA, July 19, 1985; 254(3): 400 - 402. [Abstract] [PDF]